Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.37M Sell
682,281
-417,909
-38% -$3.89M 0.01% 1013
2026
Q1
$11M Buy
+1,100,190
New +$11.4M 0.03% 587
2025
Q4
– Sell
-523,016
Closed -$4.69M – 3521
2025
Q3
$4.69M Buy
523,016
+273,609
+110% +$2.64M 0.02% 699
2025
Q2
$2.59M Buy
+249,407
New +$2.63M 0.01% 814
2024
Q4
– Sell
-401,875
Closed -$4.25M – 2732
2024
Q3
$4.25M Buy
+401,875
New +$3.89M 0.02% 539
2024
Q2
– Sell
-112,729
Closed -$957K – 2566
2024
Q1
$957K Buy
112,729
+3,954
+4% +$33K 0.01% 911
2023
Q4
$895K Buy
+108,775
New +$897K 0.01% 1046
2023
Q3
– Sell
-44,244
Closed -$370K – 2685
2023
Q2
$370K Sell
44,244
-6,770
-13% -$57.8K ﹤0.01% 1510
2023
Q1
$415K Buy
+51,014
New +$407K 0.01% 1507

Other funds holding HLN

HRT Financial's HLN Position: Q2 2026 in Review

HRT Financial reduced its Haleon (HLN) stake by 38% in Q2 2026, selling an estimated $3.89M and leaving 682,281 shares worth $6.37M. The position accounts for 0.01% of the portfolio, ranked #1013.

HRT Financial first reported a position in HLN in Q1 2023 and has held it in 9 quarters since. The position peaked at $11M in Q1 2026. 646 funds tracked by Wall St. Rank hold HLN as of Q2 2026.

  • HRT Financial held 682,281 shares of Haleon worth $6.37M as of Q2 2026.
  • HRT Financial sold 417,909 Haleon shares in Q2 2026, an estimated $3.89M.
  • Haleon made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1013 holding.
  • HRT Financial first reported a position in Haleon in Q1 2023 and has held it in 9 quarters since.
  • HRT Financial's Haleon position peaked at $11M in Q1 2026.
  • 646 funds tracked by Wall St. Rank held Haleon as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.